DK1553832T3 - Præparater og fremgangsmåder til celleseparering - Google Patents

Præparater og fremgangsmåder til celleseparering

Info

Publication number
DK1553832T3
DK1553832T3 DK03759533T DK03759533T DK1553832T3 DK 1553832 T3 DK1553832 T3 DK 1553832T3 DK 03759533 T DK03759533 T DK 03759533T DK 03759533 T DK03759533 T DK 03759533T DK 1553832 T3 DK1553832 T3 DK 1553832T3
Authority
DK
Denmark
Prior art keywords
methods
cell separation
preparations
separation preparations
reagents
Prior art date
Application number
DK03759533T
Other languages
English (en)
Inventor
Daniel P Collins
Joel H Hapke
Carol A Buchert
Original Assignee
Bioe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioe Inc filed Critical Bioe Inc
Application granted granted Critical
Publication of DK1553832T3 publication Critical patent/DK1553832T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0093—Purging against cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK03759533T 2002-09-27 2003-09-26 Præparater og fremgangsmåder til celleseparering DK1553832T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41469202P 2002-09-27 2002-09-27
PCT/US2003/030265 WO2004029208A2 (en) 2002-09-27 2003-09-26 Cell separation compositions and methods

Publications (1)

Publication Number Publication Date
DK1553832T3 true DK1553832T3 (da) 2007-10-01

Family

ID=32043402

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03759533T DK1553832T3 (da) 2002-09-27 2003-09-26 Præparater og fremgangsmåder til celleseparering

Country Status (13)

Country Link
US (1) US6933148B2 (da)
EP (1) EP1553832B1 (da)
JP (1) JP4344696B2 (da)
CN (1) CN100350040C (da)
AT (1) ATE366801T1 (da)
AU (1) AU2003275260B2 (da)
CA (1) CA2499826C (da)
DE (1) DE60314898T2 (da)
DK (1) DK1553832T3 (da)
IL (1) IL167624A (da)
MX (1) MXPA05003260A (da)
RU (1) RU2346039C2 (da)
WO (1) WO2004029208A2 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1377353A4 (en) 2001-04-10 2005-08-31 Bioergonomics Inc CELL SEPARATION COMPOSITIONS AND METHODS
US8603345B2 (en) * 2003-02-13 2013-12-10 Becton, Dickinson And Company Devices for component removal during blood collection, and uses thereof
US7670596B2 (en) 2004-04-23 2010-03-02 Bioe, Inc. Multi-lineage progenitor cells
US7622108B2 (en) 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
US8263404B2 (en) * 2005-04-08 2012-09-11 Medical Discovery Partners Llc Method for enriching rare cell subpopulations from blood
US7875453B2 (en) * 2006-06-14 2011-01-25 Bioe Llc Differentiation of multi-lineage progenitor cells to hepatocytes
US8323653B2 (en) 2006-09-08 2012-12-04 Medimmune, Llc Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
US7713688B2 (en) * 2007-01-26 2010-05-11 Bioe, Llc Methods and compositions for depleting specific cell populations from blood tissues
WO2009149382A2 (en) * 2008-06-06 2009-12-10 Baylor Research Institute Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells
CN102149473B (zh) 2008-07-21 2014-12-31 贝克顿·迪金森公司 密度相分离装置
ES2430638T3 (es) 2008-07-21 2013-11-21 Becton, Dickinson And Company Dispositivo de separación de fases por densidad
BRPI0916368B1 (pt) 2008-07-21 2020-10-06 Becton, Dickinson And Company Separador mecânico para a separação de uma amostra de fluido, conjunto de separação para possibilitar a separação de uma amostra de fluido e método de montagem de um separador mecânico
CN101403749B (zh) * 2008-11-17 2012-11-07 北京大学 通过葡聚糖特异性抗体辅助诊断自身免疫性疾病的试剂盒
EP2923765B1 (en) 2009-05-15 2021-03-17 Becton, Dickinson and Company Density phase separation device
BR122013008030B8 (pt) * 2009-09-15 2021-07-27 Univ Tokyo método para produzir células eritroides e método para produzir um produto sanguíneo
WO2012061291A2 (en) * 2010-11-01 2012-05-10 Bioe Llc Methods and compositions for cell separation of blood tissues
DK2643694T3 (da) * 2010-11-24 2018-04-16 Litron Laboratories Ltd Hurtig in vivo-genmutationsassay baseret på pig-a-genet
WO2012148549A1 (en) 2011-02-25 2012-11-01 Benaroya Research Institute Detection of an immune response
CN102839152A (zh) * 2011-06-20 2012-12-26 中国科学院上海生命科学研究院 一种快速高效获得抗原特异性b细胞的方法
EP2597153B1 (en) * 2011-11-25 2016-10-05 Miltenyi Biotec GmbH Cell separation method
WO2014165433A1 (en) * 2013-04-01 2014-10-09 Bhc Technology Holdings Llc Cell separation compositions and methods for separating and recovering therapeutic cells in blood tissue
US9694359B2 (en) 2014-11-13 2017-07-04 Becton, Dickinson And Company Mechanical separator for a biological fluid
CN108586612A (zh) * 2018-03-27 2018-09-28 深圳联合医学科技有限公司 一种适用于检测人外周血表达cd161分子亚群淋巴细胞的单克隆抗体的制备方法
RU2020122145A (ru) * 2020-07-03 2022-01-04 Петр Иванович Никитин Композиция и способ для улучшения эффективности или снижения побочных эффектов терапевтического агента, используемого для доставки нуклеиновых кислот
CN118388650B (zh) * 2024-06-28 2024-08-27 杭州赛基生物科技有限公司 一种抗CD235a单克隆抗体及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
US5877299A (en) * 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
US6117985A (en) * 1995-06-16 2000-09-12 Stemcell Technologies Inc. Antibody compositions for preparing enriched cell preparations
US6146628A (en) * 1995-07-11 2000-11-14 Regents Of The University Of Minnesota And Rutgers Biotherapeutic agents comprising recombinant PAP and PAP mutants
US6491917B1 (en) * 1998-07-31 2002-12-10 Stemcell Technologies Inc. Antibody composition for debulking blood and bone marrow samples from CML patients
US6153113A (en) * 1999-02-22 2000-11-28 Cobe Laboratories, Inc. Method for using ligands in particle separation
CN1218182C (zh) * 1999-05-28 2005-09-07 干细胞技术公司 利用免疫玫瑰花结分离细胞的方法
EP1377353A4 (en) * 2001-04-10 2005-08-31 Bioergonomics Inc CELL SEPARATION COMPOSITIONS AND METHODS

Also Published As

Publication number Publication date
CN100350040C (zh) 2007-11-21
RU2005112731A (ru) 2006-01-20
CN1735346A (zh) 2006-02-15
RU2346039C2 (ru) 2009-02-10
EP1553832A4 (en) 2006-02-01
EP1553832A2 (en) 2005-07-20
AU2003275260B2 (en) 2008-01-24
JP4344696B2 (ja) 2009-10-14
CA2499826C (en) 2015-03-24
AU2003275260A1 (en) 2004-04-19
DE60314898T2 (de) 2008-03-13
MXPA05003260A (es) 2005-09-12
EP1553832B1 (en) 2007-07-11
JP2006500932A (ja) 2006-01-12
ATE366801T1 (de) 2007-08-15
US20040062766A1 (en) 2004-04-01
IL167624A (en) 2009-12-24
DE60314898D1 (de) 2007-08-23
US6933148B2 (en) 2005-08-23
CA2499826A1 (en) 2004-04-08
WO2004029208A2 (en) 2004-04-08
WO2004029208A3 (en) 2005-04-14

Similar Documents

Publication Publication Date Title
ATE493186T1 (de) Zelltrennungszusammensetzungen und -verfahren
EP1553832A4 (en) CELL SEPARATION COMPOSITIONS AND METHODS
WO2007067782A3 (en) Compositions and methods for inducing the activation of immature monocytic dendritic cells
ATE536187T1 (de) Hla-klasse-i- und -klasse-ii-bindende peptide und ihre verwendungen
DE69802191D1 (de) Festphase nukleinsäure-isolierung
WO2004063362A3 (en) Cell cycle progression proteins
CY1111098T1 (el) Bodipy διαιθυλοακεταλη αμινοακεταλδεϋδης
ATE512666T1 (de) Hla-bindende peptide und ihre verwendungen
ATE519536T1 (de) Methode zum trennen von zellen
WO2004111075A3 (en) Alternative reading frame polypeptides for treatment
WO2004055491A3 (en) Novel method for sequence determination using nmr
EP2117592A4 (en) METHOD AND COMPOSITION FOR REMOVING SPECIFIC CELL POPULATIONS FROM BLOOD TISSUE
DK1321477T3 (da) Fremgangsmåde til frembringelsen af genetisk modificerede vertebrate precursor-lymfocytter og anvendelse deraf til fremstillingen af heterologe bindende proteiner
TW200801039A (en) Separation methods
WO2007127659A3 (en) Methods and compositions for separating cells
AU7963901A (en) Method for electrophoretically separating membrane proteins
DK1576157T3 (da) Fluorescerende proteiner fra Copepode-arter og fremgangsmåder til anvendelse af samme
DK1730276T3 (da) Fremgangsmåde, chip, indretning og system til ekstraktion af biologiske materialer
ATE483724T1 (de) Verfahren zur erhöhung der ausbreitung von b- zellen
IL180531A0 (en) Novel sequence for improving expression of nucleic acid
DK1723233T3 (da) Fremgangsmåde til berigelse og/eller adskillelse prokaryotisk DNA ved hjælp af et protein, som specifikt binder DNA indeholdende ikke-methylerede CPG-motiver
WO2004072262A3 (en) Cultured cd14+ antigen presenting cells
ES2421558T3 (es) Anticuerpos específicos de cáncer y proteínas de superficie celular
WO2004016803A3 (en) Method of enhancing cd4+ t cell responses
WO2004016743A3 (en) Culturing anaplasma